G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/02/2004	US6811980 Fixing nucleotide sequences to solid support; obtain nucleotide sequences, incubate with oxygen chemical intermediate, monitor solid suport for presence of fixed nucleotide sequences
11/02/2004	US6811979 Fluorescent nucleobase conjugates having anionic linkers
11/02/2004	US6811976 Which encodes mitochondrial dna polmerase; microsatellite sequences
11/02/2004	US6811971 Obtaining a saliva sample, preparing for detection and detecting
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811969 Retentate chromatography—profiling with biospecific interaction adsorbents
11/02/2004	US6811968 Method of monitoring cell motility and chemotaxis
11/02/2004	US6811967 Method for assaying non-spermine/spermidine activity of spermidine/spermine N1-acetyltransferase (SSAT)
11/02/2004	US6811966 Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
11/02/2004	US6811785 Multivalent MHC class II—peptide chimeras
11/02/2004	US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004	US6811776 Process for ex vivo formation of mammalian bone and uses thereof
11/02/2004	US6811753 Blood testing tool
11/02/2004	US6811751 Measurement of a person's exhalation air; correlating with concentration of water vapor
11/02/2004	US6811742 Sampler for melts
11/02/2004	US6811689 Chromatography; mass spectrometry; drug screening; proteomics
11/02/2004	US6810752 Block test stand
11/02/2004	US6810748 Method for evaluating creep lifetime
11/02/2004	US6810718 Apparatus and method for fluid analysis
11/02/2004	US6810717 Method for determining engine lubricating oil condition
11/02/2004	CA2465623A1 Method and apparatus for determining anticoagulant therapy factors
11/02/2004	CA2405888C Docking station for environmental monitoring instruments
11/02/2004	CA2372702C Water sampling with analyte extraction and integration
11/02/2004	CA2237473C Reagent system and method for the differentiation and identification of reticulocytes
11/02/2004	CA2237104C Methods of capture and assay procedures
11/02/2004	CA2220715C Functional bioassay for g-protein coupled receptor agonists and antagonists
11/02/2004	CA2163895C Simple immunochemical semi-quantitative assay method and apparatus
11/02/2004	CA2138472C Fluorescent tracer in sludge dewatering
11/02/2004	CA2098960C Bio specifically recognizing surfaces on solid supports and method for their preparation
11/02/2004	CA2068548C Automated process for preparing treated microparticles, especially blood cell components
11/02/2004	CA1341463C Cyclosporin a derivatives modified at position 1 and fluorescence polarization assay for cyclosporin a and metabolites
11/01/2004	CA2464874A1 Intraoperative lymph node assay
10/2004
10/30/2004	CA2451291A1 Test tray and test system for determining response of a biological sample
10/29/2004	CA2465799A1 Test strip with clear base support layer for visual perception of a liquid sample during application
10/28/2004	WO2004092908A2 System and method for determining optimal reaction parameters using continuously running process
10/28/2004	WO2004092742A1 Method and apparatus for monitoring hemostasis in connection with artificial surface devices
10/28/2004	WO2004092741A2 Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
10/28/2004	WO2004092740A2 Methods for identifying therapeutic targets involved in glucose and lipid metabolism
10/28/2004	WO2004092739A1 Method for mass spectrometry involving fluorescent labeling of the analyte
10/28/2004	WO2004092737A1 Diagnosis of alzheimer’s disease
10/28/2004	WO2004092735A2 Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
10/28/2004	WO2004092734A2 Novel approach to molecular diagnosis of human papilloma virus-related diseases
10/28/2004	WO2004092733A1 Reduction of migration shift assay interference
10/28/2004	WO2004092732A1 Particle having magnetic material incorporated therein, process for producing the same, particle for immunoassay and method of immunoassay
10/28/2004	WO2004092731A1 Element having bioactive substance fixed thereto
10/28/2004	WO2004092730A2 Method and device for detecting the presence of an analyte
10/28/2004	WO2004092729A2 Method for screening process conditions of a chemical coupling reaction and kits therefor
10/28/2004	WO2004092728A2 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject
10/28/2004	WO2004092727A2 Compound libraries and methods for drug discovery
10/28/2004	WO2004092726A1 Ex vivo skin organ model made of pig skin
10/28/2004	WO2004092724A2 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
10/28/2004	WO2004092719A2 Gamma ray detectors woth coincidence circuit and their use for analyzing bulk materials
10/28/2004	WO2004092718A2 Gamma ray detectors with coincidence circuit for a logging tool and their use in analyzing materials in an oil well
10/28/2004	WO2004092716A1 Method and apparatus for inspecting a substrate using a plurality of inspection wavelength regimes
10/28/2004	WO2004092712A1 Molecule detecting method, molecule counting method, molecule localization detecting method, molecule detection device used for them
10/28/2004	WO2004092707A2 Aromatic phosphonium salts and their use as labeling reagents mass spectrometry analysis
10/28/2004	WO2004092704A2 Explosives detection using differential ion mobility spectrometry
10/28/2004	WO2004092690A1 Determining gas volume, porosity, and intrinsic oxidation rate
10/28/2004	WO2004092677A1 Method and apparatus for testing fibres
10/28/2004	WO2004092405A2 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
10/28/2004	WO2004092404A2 Inhibitors of acidic mammalian chitinase as asthma therapeutics
10/28/2004	WO2004092402A1 Dual reporter/dye reduction methodology for evaluating antiviral activity and cytotoxicity of hepatitis c virus inhibitors
10/28/2004	WO2004092394A2 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
10/28/2004	WO2004092385A1 METHOD OF DETECTING β3 ADRENALINE RECEPTOR MUTANT GENE AND NUCLEIC ACID PROBE AND KIT THEREFOR
10/28/2004	WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004	WO2004092382A1 Method of detecting pancryatic islet amyloid protein mutant gene and nucleic acid probe and kit therefor
10/28/2004	WO2004092370A1 Protein capable of binding plasticizer
10/28/2004	WO2004092368A1 Method of examining obesity or emaciation
10/28/2004	WO2004092354A2 Ex vivo skin organ model, especially for human skin
10/28/2004	WO2004092353A2 Surface receptor complexes as biomarkers
10/28/2004	WO2004092342A2 Lateral flow system for nucleic acid detection
10/28/2004	WO2004092338A2 Compositions, splice variants and methods relating to cancer specific genes and proteins
10/28/2004	WO2004092336A2 Fragments of fluorescent proteins for protein fragment complementation assays
10/28/2004	WO2004092325A2 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes
10/28/2004	WO2004092322A2 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
10/28/2004	WO2004092250A1 Biocompatible material
10/28/2004	WO2004092213A1 Gene expressed in prostate cancer, methods and use thereof
10/28/2004	WO2004092211A1 Non-fluorescent report protein activateable by proteolyse for fluorescence and the use thereof for detecting protease-depending events
10/28/2004	WO2004092210A2 Molecules having immunomodulatory activity
10/28/2004	WO2004092207A2 Respiratory syncytial virus (rsv) peptides
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092198A2 Compositions and methods for the modifying hypoxia induced gene regulation
10/28/2004	WO2004092194A2 Chimeric polypeptides and their use
10/28/2004	WO2004092174A1 Pyrrolopyrroles used as fluorescent labels for biomolecules and spherical particles
10/28/2004	WO2004091646A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction
10/28/2004	WO2004091637A2 System capable of treating and defining various diseases using stem cells
10/28/2004	WO2004091558A2 Compounds for stimulating and for inhibiting melanin formation, and methods for screening these compounds
10/28/2004	WO2004091526A2 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
10/28/2004	WO2004091523A2 Method for identifying ligands specific for structural isoforms of proteins
10/28/2004	WO2004091510A2 Recombinant il-9 antibodies and uses thereof
10/28/2004	WO2004091507A2 Optimal polyvalent vaccine for cancer
10/28/2004	WO2004091491A2 Profiling conformational variants, antibody compositions and methods of using the same
10/28/2004	WO2004091481A2 Methods and kits for detecting cerebrospinal fluid in a sample
10/28/2004	WO2004091476A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease
10/28/2004	WO2004091475A2 Gaucher disease drugs and methods of identifying same
10/28/2004	WO2004091384A2 Erbb surface receptor complexes as biomarkers
10/28/2004	WO2004091383A2 Breast endothelial cell expression patterns
10/28/2004	WO2004091379A2 Assessing neuronal damage from blood samples
10/28/2004	WO2004091376A2 Medical device for monitoring blood phenylalanine levels
10/28/2004	WO2004091372A2 Methods of assessing crohn’s disease patient phenotype by i2, ompc and asca serologic response

1 ... 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 ... 3937